340B 101: Three charts show the program maximizes hospitals ’ bottom line with little consideration for patients

The 340B program was created 30 years ago to support safety-net clinics and qualifying hospitals by establishing a discounted medicine program funded by biopharmaceutical manufacturers. The aim was to help vulnerable patients access medicines at these safety-net providers. Unfortunately, the program today has become largely unrecognizable as profit incentives have fueled rapid program expansion, particularly by large hospital systems and often at the expense of patients ’ wellbeing. Here are three facts about the 340B program you may not know.
Source: The Catalyst - Category: Pharmaceuticals Tags: Drug Cost 340B Hospitals Source Type: news